We are live on ! Find out more
AAP

Aristotle Atlantic Partners Portfolio holdings

AUM $2.14B
1-Year Est. Return 37.01%
This Fund
S&P 500
This Quarter Est. Return
+10.57%
1 Year Est. Return
+37.01%
3 Year Est. Return
+123.74%
5 Year Est. Return
+154.13%
10 Year Est. Return
–
AUM
$1.52B
AUM Growth
+$149M
Cap. Flow
+$21.3M
Cap. Flow %
1.41%
Top 10 Hldgs %
42.95%
Holding
104
New
3
Increased
64
Reduced
4
Closed
3

Top Buys

Rank Stock Value
1
VRTX icon
Vertex Pharmaceuticals
VRTX
+$12.9M
2
SNOW icon
Snowflake
SNOW
+$10M
3
ADPT icon
Adaptive Biotechnologies
ADPT
+$5.7M
4
OGN icon
Organon & Co
OGN
+$1.9M
5
MSFT icon
Microsoft
MSFT
+$1.41M

Top Sells

Rank Stock Value
1
CI icon
Cigna
CI
+$16.1M
2
AYX
Alteryx Inc
AYX
+$6.07M
3
QRVO icon
Qorvo
QRVO
+$3.5M
4
MRK icon
Merck
MRK
+$2.06M
5
GTLS
Chart Industries
GTLS
+$610K

Sector Composition

Rank Sector Weight
1 Technology 30.49%
2 Healthcare 20.63%
3 Consumer Discretionary 12.82%
4 Industrials 11.64%
5 Financials 9.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GH icon
26
Guardant Health
GH
$19.5B
$23.9M 1.58%
192,707
+1,839
+1% +$247K
JPM icon
27
JPMorgan Chase
JPM
$939B
$23.9M 1.57%
153,366
+3,855
+3% +$605K
COUP
28
DELISTED
Coupa Software Incorporated
COUP
$21.4M 1.41%
81,815
+32
+0% +$7.93K
BALL icon
29
Ball Corp
BALL
$17B
$19.4M 1.28%
239,332
+2,278
+1% +$197K
DXCM icon
30
DexCom
DXCM
$27.6B
$17M 1.12%
158,812
+156
+0.1% +$15K
ROP icon
31
Roper Technologies
ROP
$36.3B
$16.8M 1.11%
35,822
+28
+0.1% +$12.4K
XOM icon
32
ExxonMobil
XOM
$651B
$16M 1.05%
253,482
– –
QRVO icon
33
Qorvo
QRVO
$7.63B
$14.5M 0.96%
74,072
-18,987
-20% -$3.5M
VRTX icon
34
Vertex Pharmaceuticals
VRTX
$121B
$12.4M 0.82%
+61,548
New +$12.9M
BMY icon
35
Bristol-Myers Squibb
BMY
$127B
$10.9M 0.72%
163,749
+3,257
+2% +$212K
AMT icon
36
American Tower
AMT
$77.7B
$10.8M 0.71%
40,000
– –
SNOW icon
37
Snowflake
SNOW
$92.9B
$10.4M 0.69%
+43,187
New +$10M
PH icon
38
Parker-Hannifin
PH
$125B
$10.1M 0.66%
32,770
– –
AMP icon
39
Ameriprise Financial
AMP
$46.8B
$9.27M 0.61%
37,243
+2,382
+7% +$600K
SAGE
40
DELISTED
Sage Therapeutics
SAGE
$9.16M 0.6%
161,205
+144
+0.1% +$10.2K
AVGO icon
41
Broadcom
AVGO
$1.82T
$8.5M 0.56%
178,310
+10,250
+6% +$475K
FIS icon
42
Fidelity National Information Services
FIS
$21.5B
$8.27M 0.55%
58,361
+2,693
+5% +$400K
PCH
43
DELISTED
PotlatchDeltic
PCH
$8.06M 0.53%
151,661
– –
BAC icon
44
Bank of America
BAC
$435B
$7.93M 0.52%
192,342
+12,279
+7% +$503K
CMCSA icon
45
Comcast
CMCSA
$79.1B
$7.75M 0.51%
135,956
+8,692
+7% +$486K
MAR icon
46
Marriott International
MAR
$98.7B
$7.57M 0.5%
55,411
+3,536
+7% +$510K
MUR icon
47
Murphy Oil
MUR
$5.58B
$6.66M 0.44%
286,155
– –
PYPL icon
48
PayPal
PYPL
$49.5B
$6.58M 0.43%
22,588
+1,309
+6% +$346K
DIS icon
49
Walt Disney
DIS
$165B
$6.38M 0.42%
36,276
+2,191
+6% +$394K
COO icon
50
Cooper Companies
COO
$13.7B
$6.34M 0.42%
64,000
– –
1
2
3 4 5

Similar funds

SC
SouthState Corp Winter Haven, Florida $2.14B AUM 18.39% 1-Year Est. Return
EF
Empirical Finance Havertown, Pennsylvania $2.13B AUM 29.56% 1-Year Est. Return
NAAA
New Age Alpha Advisors Rye, New York $2.15B AUM 27.2% 1-Year Est. Return
GA
General Atlantic New York $2.15B AUM 35.02% 1-Year Est. Return
GHA
GW Henssler & Associates Kennesaw, Georgia $2.12B AUM 20.77% 1-Year Est. Return
BCM
Basswood Capital Management New York $2.12B AUM 19.53% 1-Year Est. Return
MA
Montag & Associates Atlanta, Georgia $2.15B AUM 20.86% 1-Year Est. Return
GS
Gilead Sciences Foster City, California $2.12B AUM 143.53% 1-Year Est. Return

Aristotle Atlantic Partners's Q2 2021 Portfolio in Review

As of Q2 2021, Aristotle Atlantic Partners held 104 positions worth $1.52B, up 11% from $1.37B the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Aristotle Atlantic Partners's Q2 2021 filing shows 3 new, 64 increased, 4 reduced and 3 closed positions. Its largest new stake was Vertex Pharmaceuticals: 61,548 shares worth $12.4M. The largest sale was Cigna, an estimated $16.1M.

By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 29% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Aristotle Atlantic Partners's largest Q2 2021 buy was Vertex Pharmaceuticals: 61,548 shares worth $12.4M.
  • Aristotle Atlantic Partners added most to Adaptive Biotechnologies in Q2 2021, an estimated $5.7M increase.
  • Aristotle Atlantic Partners's biggest Q2 2021 reduction was Cigna, cutting an estimated $16.1M.
  • Aristotle Atlantic Partners fully exited Alteryx Inc in Q2 2021, selling an estimated $6.07M.
  • Aristotle Atlantic Partners's ten largest holdings make up 43% of its $1.52B portfolio in Q2 2021.
  • Aristotle Atlantic Partners opened 3 new positions and closed 3 in Q2 2021.
  • Aristotle Atlantic Partners's portfolio value rose 11% quarter-over-quarter to $1.52B.

Based on Aristotle Atlantic Partners's 13F filing for Q2 2021, filed 16 Aug 2021.